SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer
Abstract SLMO2 is a lipid transporter that transports phosphatidylserine to the interior of mitochondria, also known as PRELID3B, which plays an important role in lipid metabolism. It has also been reported to be involved in the growth process of breast and lung tumors. However, its functions and un...
Main Authors: | Xiong Liu, Renming Yuan, Jie Peng, Ailei Xu, Xiaoxia Nie, Ruiti Tang, Guangqiang Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-024-51720-5 |
Similar Items
-
Author Correction: SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer
by: Xiong Liu, et al.
Published: (2024-03-01) -
PPP1R14B Is a Prognostic and Immunological Biomarker in Pan-Cancer
by: Mingxia Deng, et al.
Published: (2021-11-01) -
PRKCSH serves as a potential immunological and prognostic biomarker in pan-cancer
by: Qiankun Wang, et al.
Published: (2024-01-01) -
Pan-cancer analysis of the prognostic and immunological role of ANLN: An onco-immunological biomarker
by: Kejun Liu, et al.
Published: (2022-08-01) -
Pan-Cancer Analysis of FURIN as a Potential Prognostic and Immunological Biomarker
by: Bolun Zhou, et al.
Published: (2021-04-01)